COVID-19 Updates, April 7: Face Coverings, Testing, & MedicationsIt is common to feel overwhelmed about COVID-19: so much information changing day-to-day. Here are some of the important COVID-19 stories that...reactionscomments
Sodium Oxybate Trials, Pediatric Research, and Narcolepsy Comorbidities in the NewsWorld Narcolepsy Day falls annually on September 22. The following news briefs cover recent research of interest to people living with narcolepsy...reactions2comments
Xywav® (calcium, magnesium, potassium, and sodium oxybate) Approved for Idiopathic Hypersomnia in AdultsOn August 12, 2021, the U.S. Food and Drug Administration (FDA) approved Xywav® (calcium, magnesium, potassium, and sodium oxybate) oral solution to...reactions2comments
COVID-19 Updates, July 16: Updates on People at Risk, Testing, Reopening, and a VaccineEven after months of navigating life in the COVID-19 era, keeping up with new information and news can be overwhelming. Below are...reactionscomments
COVID-19 Basics for the Immune-CompromisedFor those living with chronic health conditions, current news about the coronavirus (COVID-19) can be anxiety-inducing. We have questions and concerns about...reactionscomments
Wakix® Becomes First and Only Non-Controlled Drug Approved for Cataplexy Due to NarcolepsyThe U.S. Food and Drug Administration (FDA) has approved Wakix® (pitolisant) for the treatment of cataplexy in adults with narcolepsy. This makes...reactionscomments
FDA Makes Way For New Experimental Drugs to Fight COVID-19On March 19, the U.S. Food and Drug Administration (FDA) approved the testing of two drugs, chloroquine (hydroxychloroquine) and remdesivir, to treat...reactionscomments
